In this single-center , open-label , randomized , three-treatment crossover study , 36 healthy volunteers were randomized to receive a single 90-mg dose of ticagrelor administered orally as a whole tablet or as crushed tablets suspended in water and given orally or via a nasogastric tube into the stomach , with a minimum 7-day wash-out between treatments .